Resultados da pesquisa - Roderich E. Schwarz

  • A mostrar 1 - 16 resultados de 16
Refinar resultados
  1. 1
    Profile of nintedanib in the treatment of solid tumors: the evidence to date

    Profile of nintedanib in the treatment of solid tumors: the evidence to date Por Niranjan Awasthi, Roderich E. Schwarz

    Publicado em 2015
    Obter o texto integral Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  2. 2
    Extended Lymph Node Dissection for Gastric Cancer: Who May Benefit? Final Results of the Randomized Dutch Gastric Cancer Group Trial

    Extended Lymph Node Dissection for Gastric Cancer: Who May Benefit? Final Results of the Randomized Dutch Gastric Cancer Group Trial Por Roderich E. Schwarz, David Smith

    Publicado em 2005
    Obter o texto integral Obter o texto integral
    Carta
    Adic. favoritos
    Na minha lista:
  3. 3
    Subcutaneously implanted central venous access devices in cancer patients: a prospective analysis.

    Subcutaneously implanted central venous access devices in cancer patients: a prospective analysis. Por Roderich E. Schwarz, Jeffrey S. Groeger, Daniel G. Coit

    Publicado em 1997
    Artigo
    Adic. favoritos
    Na minha lista:
  4. 4
    Subcutaneously implanted central venous access devices in cancer patients

    Subcutaneously implanted central venous access devices in cancer patients Por Roderich E. Schwarz, Jeffrey S. Groeger, Daniel G. Coit

    Publicado em 1997
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  5. 5
    BMS-754807, a Small-Molecule Inhibitor of Insulin-like Growth Factor-1 Receptor/Insulin Receptor, Enhances Gemcitabine Response in Pancreatic Cancer

    BMS-754807, a Small-Molecule Inhibitor of Insulin-like Growth Factor-1 Receptor/Insulin Receptor, Enhances Gemcitabine Response in Pancreatic Cancer Por Niranjan Awasthi, Changhua Zhang, Winston Ruan, Margaret A. Schwarz, Roderich E. Schwarz

    Publicado em 2012
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  6. 6
    Endothelial monocyte activating polypeptide II interferes with VEGF-induced proangiogenic signaling

    Endothelial monocyte activating polypeptide II interferes with VEGF-induced proangiogenic signaling Por Niranjan Awasthi, Margaret A. Schwarz, Varun Verma, Clint D. Cappiello, Roderich E. Schwarz

    Publicado em 2008
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  7. 7
    Nintedanib, a triple angiokinase inhibitor, enhances cytotoxic therapy response in pancreatic cancer

    Nintedanib, a triple angiokinase inhibitor, enhances cytotoxic therapy response in pancreatic cancer Por Niranjan Awasthi, Stefan Hinz, Rolf A. Brekken, Margaret A. Schwarz, Roderich E. Schwarz

    Publicado em 2014
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  8. 8
    Functional and phenotypic analysis of tumor-infiltrating. Lymphocytes isolated from human primary and metastatic. Liver tumors and cultured in recombinant interleukin-2

    Functional and phenotypic analysis of tumor-infiltrating. Lymphocytes isolated from human primary and metastatic. Liver tumors and cultured in recombinant interleukin-2 Por Shojiro Takagi, Kangnian Chen, Roderich E. Schwarz, Shunzaburo Iwatsuki, Ronald B. Herberman, Theresa L. Whiteside

    Publicado em 1989
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  9. 9
    Systemic cytotoxic and biological therapies of colorectal liver metastases: expert consensus statement

    Systemic cytotoxic and biological therapies of colorectal liver metastases: expert consensus statement Por Roderich E. Schwarz, Jordan Berlin, Heinz Josef Lenz, Bernard Nordlinger, Laura Rubbia‐Brandt, Michael A. Choti

    Publicado em 2012
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  10. 10
    PG545, an Angiogenesis and Heparanase Inhibitor, Reduces Primary Tumor Growth and Metastasis in Experimental Pancreatic Cancer

    PG545, an Angiogenesis and Heparanase Inhibitor, Reduces Primary Tumor Growth and Metastasis in Experimental Pancreatic Cancer Por Katherine T. Ostapoff, Niranjan Awasthi, Bercin Kutluk Cenik, Stefan Hinz, Keith Dredge, Roderich E. Schwarz, Rolf A. Brekken

    Publicado em 2013
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  11. 11
    Nonoperative therapies for combined modality treatment of hepatocellular cancer: expert consensus statement

    Nonoperative therapies for combined modality treatment of hepatocellular cancer: expert consensus statement Por Roderich E. Schwarz, Ghassan K. Abou‐Alfa, Jeffrey F. Geschwind, Sunil Krishnan, Riad Salem, Alan P. Venook

    Publicado em 2010
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  12. 12
    Comparative benefits of Nab-paclitaxel over gemcitabine or polysorbate-based docetaxel in experimental pancreatic cancer

    Comparative benefits of Nab-paclitaxel over gemcitabine or polysorbate-based docetaxel in experimental pancreatic cancer Por Niranjan Awasthi, Chenyue Zhang, Anna Schwarz, Stefan Hinz, C. Wang, Noelle S. Williams, Margaret A. Schwarz, Roderich E. Schwarz

    Publicado em 2013
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  13. 13
    Apricoxib, a Novel Inhibitor of COX-2, Markedly Improves Standard Therapy Response in Molecularly Defined Models of Pancreatic Cancer

    Apricoxib, a Novel Inhibitor of COX-2, Markedly Improves Standard Therapy Response in Molecularly Defined Models of Pancreatic Cancer Por Amanda Kirane, Jason E. Toombs, Katherine T. Ostapoff, Juliet G. Carbon, Sara Zaknoen, Jordan Braunfeld, Roderich E. Schwarz, Francis Burrows, Rolf A. Brekken

    Publicado em 2012
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  14. 14
    Endothelial-Monocyte Activating Polypeptide Ii, a Novel Antitumor Cytokine That Suppresses Primary and Metastatic Tumor Growth and Induces Apoptosis in Growing Endothelial Cells

    Endothelial-Monocyte Activating Polypeptide Ii, a Novel Antitumor Cytokine That Suppresses Primary and Metastatic Tumor Growth and Induces Apoptosis in Growing Endothelial Cells Por Margaret A. Schwarz, Jessica J. Kandel, Jerald Brett, Jun Li, Joanne Hayward, Roderich E. Schwarz, Olivier Chappey, Jean-Luc Wautier, John A. Chabot, Paul Lo Gerfo, David M. Stern

    Publicado em 1999
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  15. 15
    A Phase I Dose-Escalation Trial of Single-Fraction Stereotactic Radiation Therapy for Liver Metastases

    A Phase I Dose-Escalation Trial of Single-Fraction Stereotactic Radiation Therapy for Liver Metastases Por Jeffrey Meyer, Ryan Foster, Naama Lev‐Cohain, Takeshi Yokoo, Ying Dong, Roderich E. Schwarz, William G. Rule, Jing Tian, Yang Xie, Raquibul Hannan, Lucien Nedzi, Timothy D. Solberg, Robert Timmerman

    Publicado em 2015
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  16. 16
    Alternating Systemic and Hepatic Artery Infusion Therapy for Resected Liver Metastases From Colorectal Cancer: A North Central Cancer Treatment Group (NCCTG)/ National Surgical Adjuvant Breast and Bowel Project (NSABP) Phase II Intergroup Trial, N9945/CI-66

    Alternating Systemic and Hepatic Artery Infusion Therapy for Resected Liver Metastases From Colorectal Cancer: A North Central Cancer Treatment Group (NCCTG)/ National Surgical Adj... Por Steven R. Alberts, Mark S. Roh, Michelle R. Mahoney, Michael J. OʼConnell, David M. Nagorney, Lawrence D. Wagman, Thomas C. Smyrk, Timothy L. Weiland, Lily Lai, Roderich E. Schwarz, R Molina, Todor Dentchev, John S. Bolton

    Publicado em 2010
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:

Ferramentas de pesquisa: